 
|
 Biopharmaceuticals
 Clinical stage biotech company pursuing transformative
approach to treating chronic pain and related conditions. Spin out of assets
from Roche.
Boston, MA  Biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
Boulder, CO  Clinical stage biotechnology company focused on developing novel oral state-dependent calcium channel (CaV 2.2) modulators for chronic pain.
Cambridge, UK  Developer of new antiviral medicines for the treatment of life-threatening diseases.
Ticker: CMRX Durham, NC  Novel product platform focused on generating new NCEs
through the use of deuterium based chemistry on the known molecular
structures of approved pharmaceutical products.
Lexington, MA  Biotechnology company developing novel analgesics based on
state dependent ion channel pharmacology and medicinal chemistry platform.
Cambridge, UK  Clinical stage biopharma company focused on completing phase
3 clinical development and registration of dalbavancin, a late stage
lipoglycopeptide antibiotic. Spin out of Vicuron division of Pfizer.
Ticker: DRTX North Morristown, NJ  Product platform company with a novel, implantable osmotic
pump. Lead program is exenatide, for the treatment of type 2 diabetes.
Emeryville, CA  Biopharmaceutical company focused on the development of therapeutics for liver disease.
Ticker: ICPT New York, NY  Product platform biopharmaceutical company pursuing an
industrial approach to pathway-based drug discovery.
San Diego, CA  A pharmaceutical company focused on bone related diseases.
New Haven, CT  An emerging pharmaceutical company focusing on drug discovery and development of molecular-targeted, small-molecule drugs to treat cancer and inflammation.
Southampton, UK  Oncology company focused on the clinical development of novel therapies for cancer.
Ticker: MEIP San Diego, CA  Early clinical stage biotech company focused on novel
treatments for Hepatitis- C and HIV.
San Francisco, CA  Start up company focused on advancing best in class medicines in immunology, autoimmune diseases and oncology using their proprietary chemistry platform.
South San Francisco, CA  Clinical stage product platform company focused on
development of novel products for the treatment and prevention of
inflammatory, obstructive and allergic conditions in respiratory diseases.
Spin out of technology from Nektar.
Redwood City, CA  Clinical stage product platform company targeting discovery
and development of non-absorbed polymeric drugs in cardiovascular and renal
diseases. Spinout of technology from Amgen/Ilypsa.
Santa Clara, CA  Clinical stage oncology company with lead program in phase 3
in first-line metastatic breast cancer.
New Haven, CT  Clinical stage biopharmaceutical company with a phase 3
program in irritable bowel syndrome. Spin out of asset from Merck KgA.
San Diego, CA  NDA stage specialty pharmaceutical company developing
products that utilize a buccal delivery technology. Lead program in
insomnia.
Ticker: TSPT Pt. Richmond, CA  Clinical stage product platform company developing vaccines
for both pandemic and seasonal influenza.
Cranbury, NJ  Clinical stage biotech company pursuing a monthly hGH using Amunix’s XTEN technology.
Mountain View, CA |